February 22, 2021

Twist Bioscience and Berry Genomics to Offer New NGS Solution to Advance Research and Precision Medicine

SOUTH SAN FRANCISCO, Calif.–(BUSINESS WIRE)– #DNA–Twist Bioscience Corporation (NASDAQ: TWST), a company enabling customers to succeed through its offering of high-quality synthetic DNA using its silicon platform, today announced that Berry Genomics, a leading commercial next-generation sequencing (NGS) provider in China, will add Twist’s NGS target enrichment and library preparation tools to its offering. The product offering combines the genomic and next generation sequencing expertise of Berry G

Leave Comment

Your Name *
Your Email *
Your Website
Comment *